title: Clinical case: Peritoneal dialysis patient with cloudy peritoneal fluid following administration of calcium antagonists.
authors.forename: M C
authors.initials: MC
authors.lastname: Viñolo López
authors.forename: P C
authors.initials: PC
authors.lastname: Gutiérrez Rivas
authors.forename: A
authors.initials: A
authors.lastname: Liébana Cañada
authors.forename: J M
authors.initials: JM
authors.lastname: Gil Cunquero
authors.forename: E
authors.initials: E
authors.lastname: Merino García
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001202:Ascitic Fluid / Q000737:chemistry*; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002915:Chylous Ascites / Q000139:chemically induced* / Q000175:diagnosis; D003937:Diagnosis, Differential; D004095:Dihydropyridines / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000628:therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy; D009543:Nifedipine / Q000009:adverse effects / Q000627:therapeutic use; D009578:Nitrobenzenes; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000175:diagnosis; D010879:Piperazines; D012189:Retrospective Studies; D014280:Triglycerides / Q000032:analysis
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D004095:Dihydropyridines; D009578:Nitrobenzenes; D010879:Piperazines; D014280:Triglycerides; C054218:manidipine; D009543:Nifedipine